SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-064420
Filing Date
2021-12-09
Accepted
2021-12-09 16:20:04
Documents
3
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea152025-6k_universepha.htm 6-K 14531
2 LETTER OF FRIEDMAN LLP TO THE U.S. SECURITIES AND EXCHANGE COMMISSION DATED DECE ea152025ex99-1_universepha.htm EX-99.1 3499
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6306
  Complete submission text file 0001213900-21-064420.txt   27951
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 211482225
SIC: 2834 Pharmaceutical Preparations